Clinical Trial Update: Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial update evaluating the immunogenicity and safety of a single prime-boost schedule for an H5N1 influenza vaccine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• H5N1 influenza vaccine (single prime-boost) (Influenza vaccine, H5N1)

Snippet

Sponsor: Alachua Government Services, Inc. | Conditions: Influenza, Avian Influenza | Phase 1, Phase 2 | Status: COMPLETED